MoneyWorks4Me

Indoco Remedies informs about disclosure

27 Nov 2024 Evaluate

Indoco Remedies has enclosed herewith the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 in regards to the purchase of 8,232 equity shares from the Open Market on November 27, 2024. 

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..